Skip to main content
. 2023 May 8;21(4):343–354. doi: 10.18502/ijrm.v21i4.13273

Table 2.

Baseline characteristics of study subjects


Group
Variables PBMC-treated (n = 10) Control (n = 10) P-value
Age (yr)* 33.10 ± 2.80 (27-37) 34.70 ± 2.49 (30-38) 0.19
BMI (kg/m2)* 24.34 ± 3.12 (19.8-27.6) 24.63 ± 3.43 (20.4-28.9) 0.84
No. of previous implantation failure* 4.20 ± 3.11 (3-13) 4.30 ± 2.40 (3-11) 0.93
Data presented as Mean ± SD (minimum-maximum) t test, PBMC: Peripheral blood mononuclear cells, BMI: Body mass index